Vogenx Inc
Last updated September 27, 2026
Organization details
- Legal name
- Vogenx Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Raleigh
- Headquarters state / province
- North Carolina
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- VOGX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001903784
- EIN
- 86-3697324
Board of directors
-
James Green · Director · Chief Executive OfficerSince 2026
-
Kenneth John Toombs · DirectorSince 2026
-
Peter Pieraccini · DirectorSince 2026
-
Richard M. Gorman · DirectorSince 2026
-
Steven R. Delmar · Director · Chief Financial OfficerSince 2026
-
Timothy Boris · DirectorSince 2026
-
William Wilkison · Director · Chief Scientific OfficerSince 2026
Chief executives
James Green
· Chief Executive Officer
Since August 2026
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 13, 2026 | Steven R. Delmar Director, Officer (Chief Financial Officer) | Derivative conversion | +4,273 | $11.70 | $49,994 |
| Aug 13, 2026 | Peter Pieraccini Director | Derivative conversion | +42,735 | $11.70 | $500,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.